Research Summary
Analyzed using Evidence Intelligence™

New education program improves glycemic outcomes for insulin pump users

Last updated September 9, 2026

Key finding

between-group difference in change was 13.5% [95% CI: 4.0 to 22.9], p = 0.0064

This study evaluated a new education program for insulin pump users transitioning to a different pump. The program significantly improved time in range and psychosocial self-efficacy compared to usual care.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated a new education program for insulin pump users transitioning to a different pump. The program significantly improved time in range and psychosocial self-efficacy compared to usual care.

Clinical relevance

Improving time in range and psychosocial self-efficacy is crucial for insulin pump users, as better blood sugar control can reduce the risk of diabetes-related complications. This study highlights the importance of tailored education programs in enhancing the management of diabetes, particularly during transitions to new devices.

Keep in mind

The study's sample size and demographics may limit generalizability. The effectiveness of the program was not assessed over a long-term period. Potential biases in self-reported measures could affect outcome accuracy.

Published in

Journal Reference

Publication details and source links for this paper.

Karen R, Anette H, Anne GS, Nermin S, Ajenthen GR, Kirsten N. A new education program for insulin pump users transitioning to a different pump. Acta Diabetologica. 2024;62(1):87-94. doi:10.1007/s00592-024-02340-y

Main Effects

The NP group had a 13.5% increase in mean TIR compared to UC (p = 0.0064).

Psychosocial self-efficacy improved significantly in the NP group.

HbA1c decreased significantly in the NP group.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to New Program (NP), Usual care and HbA1c, Psychosocial Self-Efficacy (DES-SF), Time in range.

Primary intervention

New Program (NP)

Primary outcomes

  • HbA1c
  • Psychosocial Self-Efficacy (DES-SF)
  • Time in range

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
3
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

3

Related topics

6

Evidence pairs

1125

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

CGM Time in Range

matched_outcome

Related evidence

Evidence topic

Glycemic Control

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

HbA1c

New Program (NP) → HbA1c

New Program (NP) → HbA1c

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Psychosocial Self-Efficacy (DES-SF)

New Program (NP) → Psychosocial Self-Efficacy (DES-SF)

New Program (NP) → Psychosocial Self-Efficacy (DES-SF)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Time in range

New Program (NP) → Time in range

New Program (NP) → Time in range

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HbA1c

Usual care → HbA1c

Usual care → HbA1c

Evidence Intelligence™
EvidenceScore™
86
Strong
ImpactScore™
58
Slightly Positive
ConsistencyScore™
92
consistent
Supporting studies: Based on 13 studies
Add to Evidence Tracker

Psychosocial Self-Efficacy (DES-SF)

Usual care → Psychosocial Self-Efficacy (DES-SF)

Usual care → Psychosocial Self-Efficacy (DES-SF)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Time in range

Usual care → Time in range

Usual care → Time in range

Evidence Intelligence™
EvidenceScore™
78
Strong
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Supporting studies: Based on 3 studies
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Mean TIR increased by 13.5% in the NP group (p = 0.0064).
  • Psychosocial self-efficacy improved significantly in the NP group.
  • HbA1c levels decreased significantly in the NP group.
who this applies

Who this applies to

  • Adults transitioning to a different insulin pump.
  • Individuals with diabetes using insulin pumps.
keep in mind

Keep in Mind

  • Results may not apply to populations outside the study sample.
  • The study did not evaluate long-term effects of the education program.
  • Self-reported outcomes may introduce bias in the findings.
between the lines

Between the Lines

  • The study's sample size and demographics may limit generalizability.
  • The effectiveness of the program was not assessed over a long-term period.
  • Potential biases in self-reported measures could affect outcome accuracy.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Usual care and HbA1c, Usual care and CGM Time in Range.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Usual care lower HbA1c?

Strong Evidence

Usual care may lower HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 85.8 | weak positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Usual care improve time in range?

Strong Evidence

Current evidence does not show a clear benefit of Usual care for time in range.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Time in range

    EvidenceScore™ Strong | EvidenceScore™ 78.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does New Program (NP) lower HbA1c?

Emerging Evidence

New Program (NP) appears to lower HbA1c.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does New Program (NP) improve psychosocial self-efficacy (DES-SF)?

Emerging Evidence

New Program (NP) appears to improve psychosocial self-efficacy (DES-SF).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Psychosocial Self-Efficacy (DES-SF)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.